Smith 2005.
Methods | Participants were allocated using computer-generated randomisation codes prepared in advance. Randomisation and the ordering of spectacles were performed by a principal investigator who had no contact with participants during the study. Masking: Participant: yes Provider: no; Outcome: yes. Exclusions after randomisation: None reported. Losses to follow-up: 10 in the custom prism group, 6 in the standard prism group, and 2 in the placebo group |
|
Participants | Country: UK Number randomised: 243 individuals with AMD at Manchester Royal Eye Hospital,England. Age: mean 81 years Sex: women 65% Inclusion criteria: English-speaking. Exclusion criteria: illiterate, resident in a hospital or a nursing home. Study duration: 3 months follow-up during the period July 15, 2001, through March31, 2003 |
|
Interventions | Treatment: 3 types of test spectacles:
|
|
Outcomes |
|
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Participants were allocated to a group using computer-generated randomisation codes prepared in advance |
Allocation concealment (selection bias) | Low risk | Randomisation and the ordering of spectacles were performed by a principal investigator who had no contact with participants during the study |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Low number of losses to follow-up: 10 in the custom prism group, 6 in the standard prism group, and 2 in the placebo group |
Selective reporting (reporting bias) | Low risk | No protocol available, but primary outcome reported |
Other bias | Low risk | No other bias identified |